Jiangsu Hengrui | 600276 - Equity Capital And Reserves


Jiangsu Hengrui reported CNY59.5B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Cspc Pharmaceutical CNY 33.25B 984.93M Jun/2025
Kangmei Pharma CNY 7.22B 504.3M Sep/2025
Sh Fosun Pharma CNY 60.81B 12.74B Sep/2025
Sh Pharmaceutical CNY 75.78B 13.08B Sep/2025
Sino Biopharmaceutical CNY 34B 1.48B Jun/2025
Wuxi Apptec CNY 71.47B 11.56B Sep/2025
Zz Pientze Pharmaceu CNY 14.47B 173.2M Sep/2025